Post-authorization Safety Study of Etoricoxib and Other Anti-inflammatory Therapies in European Patients With Ankylosing Spondylitis (MK-0663-163)
Condition(s):Ankylosing SpondylitisLast Updated:February 18, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Ankylosing SpondylitisLast Updated:February 18, 2022Completed
Condition(s):Vestibular Disorder; Headache; Traumatic Brain InjuryLast Updated:June 24, 2020Completed
Condition(s):InflammationLast Updated:August 1, 2017Completed
Condition(s):HypertensionLast Updated:February 5, 2021Completed
Condition(s):Moderate to Severe Dry Eye SyndromeLast Updated:January 3, 2014Completed
Condition(s):Femoroacetabular Impingement; Hip Arthroscopy; Hip Osteoarthritis; Hydrolyzed Collagen PeptidesLast Updated:January 30, 2024Completed
Condition(s):GlaucomaLast Updated:October 26, 2022Active, not recruiting
Condition(s):Spinal Cord Injury; InflammationLast Updated:January 17, 2023Completed
Condition(s):Ulcerative ColitisLast Updated:February 11, 2021Unknown status
Condition(s):Overweight; ObesityLast Updated:December 9, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.